Compare HELE & ALVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HELE | ALVO |
|---|---|---|
| Founded | 1968 | 2013 |
| Country | United States | Luxembourg |
| Employees | 1854 | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 883.5M | 1.0B |
| IPO Year | 1996 | 2021 |
| Metric | HELE | ALVO |
|---|---|---|
| Price | $37.48 | $4.84 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 4 | 6 |
| Target Price | ★ $31.67 | $7.20 |
| AVG Volume (30 Days) | 643.3K | ★ 810.1K |
| Earning Date | 10-08-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.69 | N/A |
| Revenue | ★ $1,478,845,000.00 | N/A |
| Revenue This Year | $0.95 | $10.83 |
| Revenue Next Year | $1.50 | $20.41 |
| P/E Ratio | $21.51 | ★ $18.20 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.85 | $2.94 |
| 52 Week High | $37.79 | $6.53 |
| Indicator | HELE | ALVO |
|---|---|---|
| Relative Strength Index (RSI) | 74.43 | 47.24 |
| Support Level | $25.35 | $3.10 |
| Resistance Level | N/A | $5.43 |
| Average True Range (ATR) | 1.42 | 0.23 |
| MACD | 0.97 | -0.01 |
| Stochastic Oscillator | 86.64 | 39.29 |
Helen Of Troy Ltd is a consumer products company offering creative products and solutions for its customers through a diversified portfolio of brands. It has two operating segments: Home and Outdoor segment provides a broad range of consumer products for home activities such as food preparation, cooking, cleaning, and organization; as well as products for outdoor and on-the-go activities such as hydration, food storage, backpacks, and travel gear, and The Beauty and Wellness segment provides beauty and wellness products including mass and prestige market beauty appliances, prestige market liquid-based hair and personal care products, and wellness devices including thermometers, water and air filtration systems, humidifiers, and fans.
Alvotech is a biopharmaceutical company focused solely on the development and manufacture of biosimilar medicines for patients globally. Its purpose is to improve the health and quality of life of patients around the world by improving access to treatments for various diseases. The company's commercialized products incldue AVT02, AVT03, AVT04, AVT05, and AVT06. Its pipeline contains eight biosimilar candidates aimed at treating autoimmune disorders, eye disorders, osteoporosis, and cancer. Geographically, the company generates the majority of revenue from Europe, and the rest from the USA and the rest of the world.